Clinical trial · NCT07545577
Randomized Controlld Trial of Dementia Education Resources for Action
Sponsor: George Mason University
Summary
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.
Interventions
- DERA Online Training Program · BEHAVIORAL
The Dementia Education and Resources for Action (DERA) program is a structured, online training intervention designed for community health workers. The program consists of approximately 7 sessions delivered through a web-based platform. Content includes dementia fundamentals, early signs and risk factors, stigma reduction, and strategies for communication, support, and service navigation. The training incorporates video-based instruction, interactive materials, and quizzes to support learning and engagement.
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Age 18 years or older * Currently working as a community health worker or serving in a community health worker-related role * Able to read and understand English * Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys * Willing and able to provide informed consent Exclusion Criteria: * Previously completed the DERA training program * Unable to complete study procedures in English * Unable to access the online training platform or study surveys
Sites (1)
- Online, Fairfax, Virginia · Recruiting
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-09-11.